These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32702292)

  • 21. Lipid compositional analysis of pulmonary surfactant monolayers and monolayer-associated reservoirs.
    Yu SH; Possmayer F
    J Lipid Res; 2003 Mar; 44(3):621-9. PubMed ID: 12562850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cholesterol on surface activity and surface topography of spread surfactant films.
    Diemel RV; Snel MM; Van Golde LM; Putz G; Haagsman HP; Batenburg JJ
    Biochemistry; 2002 Dec; 41(50):15007-16. PubMed ID: 12475250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An investigation of the carbon nanotube--Lipid interface and its impact upon pulmonary surfactant lipid function.
    Melbourne J; Clancy A; Seiffert J; Skepper J; Tetley TD; Shaffer MS; Porter A
    Biomaterials; 2015 Jul; 55():24-32. PubMed ID: 25934449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adsorption of pulmonary surfactant protein SP-A to monolayers of phospholipids containing hydrophobic surfactant protein SP-B or SP-C: potential differential role for tertiary interaction of lipids, hydrophobic proteins, and SP-A.
    Taneva SG; Keough KM
    Biochemistry; 2000 May; 39(20):6083-93. PubMed ID: 10821681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrical surface potential of pulmonary surfactant.
    Leonenko Z; Rodenstein M; Döhner J; Eng LM; Amrein M
    Langmuir; 2006 Nov; 22(24):10135-9. PubMed ID: 17107011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative assessment of inhaled drug particle-pulmonary surfactant interaction by atomic force microscopy.
    Davies MJ; Brindley A; Chen X; Doughty SW; Marlow M; Roberts CJ
    Colloids Surf B Biointerfaces; 2009 Oct; 73(1):97-102. PubMed ID: 19500951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol modifies the properties of surface films of dipalmitoylphosphatidylcholine plus pulmonary surfactant-associated protein B or C spread or adsorbed at the air-water interface.
    Taneva S; Keough KM
    Biochemistry; 1997 Jan; 36(4):912-22. PubMed ID: 9020791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of multilayers in preventing the premature buckling of the pulmonary surfactant.
    Al-Saiedy M; Tarokh A; Nelson S; Hossini K; Green F; Ling CC; Prenner EJ; Amrein M
    Biochim Biophys Acta Biomembr; 2017 Aug; 1859(8):1372-1380. PubMed ID: 28501605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The surface-associated surfactant reservoir in the alveolar lining.
    Schürch S; Qanbar R; Bachofen H; Possmayer F
    Biol Neonate; 1995; 67 Suppl 1():61-76. PubMed ID: 7647159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films. I. Micro- and nanostructures of functional pulmonary surfactant films and the effect of SP-A.
    Zuo YY; Keating E; Zhao L; Tadayyon SM; Veldhuizen RA; Petersen NO; Possmayer F
    Biophys J; 2008 May; 94(9):3549-64. PubMed ID: 18212010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adsorption, compression and stability of surface films from natural, lipid extract and reconstituted pulmonary surfactants.
    Yu SH; Possmayer F
    Biochim Biophys Acta; 1993 Apr; 1167(3):264-71. PubMed ID: 8481387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular interactions of cord factor with dipalmitoylphosphatidylcholine monolayers: implications for lung surfactant dysfunction in pulmonary tuberculosis.
    Chimote G; Banerjee R
    Colloids Surf B Biointerfaces; 2008 Aug; 65(1):120-5. PubMed ID: 18455914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.
    Zhang H; Wang YE; Neal CR; Zuo YY
    Pediatr Res; 2012 Apr; 71(4 Pt 1):316-23. PubMed ID: 22391630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of clinical pulmonary surfactants using atomic force microscopy.
    Zhang H; Fan Q; Wang YE; Neal CR; Zuo YY
    Biochim Biophys Acta; 2011 Jul; 1808(7):1832-42. PubMed ID: 21439262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface activity in vitro: role of surfactant proteins.
    Possmayer F; Nag K; Rodriguez K; Qanbar R; Schürch S
    Comp Biochem Physiol A Mol Integr Physiol; 2001 May; 129(1):209-20. PubMed ID: 11369545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural Changes in Films of Pulmonary Surfactant Induced by Surfactant Vesicles.
    Andreev K; Martynowycz MW; Kuzmenko I; Bu W; Hall SB; Gidalevitz D
    Langmuir; 2020 Nov; 36(45):13439-13447. PubMed ID: 33080138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palmitoylation of a pulmonary surfactant protein C analogue affects the surface associated lipid reservoir and film stability.
    Gustafsson M; Palmblad M; Curstedt T; Johansson J; Schürch S
    Biochim Biophys Acta; 2000 Jun; 1466(1-2):169-78. PubMed ID: 10825440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pulmonary surfactant protein A and neutral lipid on accretion and organization of dipalmitoylphosphatidylcholine in surface films.
    Yu SH; Possmayer F
    J Lipid Res; 1996 Jun; 37(6):1278-88. PubMed ID: 8808762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorocarbon-hybrid pulmonary surfactants for replacement therapy--a Langmuir monolayer study.
    Nakahara H; Lee S; Krafft MP; Shibata O
    Langmuir; 2010 Dec; 26(23):18256-65. PubMed ID: 21049919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of surfactant proteins in DPPC enrichment of surface films.
    Veldhuizen EJ; Batenburg JJ; van Golde LM; Haagsman HP
    Biophys J; 2000 Dec; 79(6):3164-71. PubMed ID: 11106621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.